Publications by authors named "Jens Modrof"

Claim this Profile
D
Detection of Minute virus of mice strains in different cell lines: Implications for adventitious agent testing.
Maria R Farcet, Jens Modrof, Gerhard Antoine, Cecilie Klausen, Astrid Kerschbaum

Biotechnol Bioeng· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of biomanufacturing processes from virus contamination through upstream virus filtration of cell culture media.
Andreas Wieser, Jens Modrof, Thomas R Kreil

Biotechnol Bioeng· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical evaluation of the in vivo adventitious virus test and its potential for replacement with next generation sequencing (NGS).
Paul W Barone, Flora J Keumurian, Caleb Neufeld, Andrea Koenigsberg, Robert Kiss, Jens Modrof

Biologicals· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 and the safety margins of cell-based biological medicinal products.
Jens Modrof, Astrid Kerschbaum, Maria R Farcet, Daniela Niemeyer, Victor M Corman

Biologicals· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus disinfection for biotechnology applications: Different effectiveness on surface versus in suspension.
Johanna Kindermann, Michael Karbiener, Sandra M Leydold, Simone Knotzer, Jens Modrof

Biologicals· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continued use of poliovirus after eradication: hyper-attenuated strains as a safe alternative for release testing of human immunoglobulins.
Maria R Farcet, Jens Modrof, Philip O Rabel, Andreas Schirmer, Andrew J Macadam

Transfusion· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel evaluation of broad virus detection methods.
Jens Modrof, Andreas Berting, Thomas R Kreil

PDA J Pharm Sci Technol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
Jens Modrof, Björn Tille, Maria R Farcet, John McVey, Jessica A Schreiner

J Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes.
Maria R Farcet, Cornelia Lackner, Gerhard Antoine, Philip O Rabel, Andreas Wieser, Jens Modrof

Transfusion· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the effectiveness of gaseous virus disinfectants.
Simone Knotzer, Johanna Kindermann, Jens Modrof, Thomas R Kreil

Biologicals· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine.
Cornelia Lackner, Sandra M Leydold, Jens Modrof, Maria R Farcet, Leopold Grillberger

Vaccine· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chikungunya virus and the safety of plasma products.
Sandra M Leydold, Maria R Farcet, Johanna Kindermann, Jens Modrof, Gerhard Pölsler

Transfusion· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of hepatitis A variants during heat treatment (pasteurization) of human serum albumin.
Maria R Farcet, Johanna Kindermann, Jens Modrof, Thomas R Kreil

Transfusion· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis A virus antibodies in immunoglobulin preparations.
Maria R Farcet, Christina B Planitzer, Oliver Stein, Jens Modrof, Thomas R Kreil

J Allergy Clin Immunol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
West Nile virus infection in plasma of blood and plasma donors, United States.
Christina B Planitzer, Jens Modrof, Mei-ying W Yu, Thomas R Kreil

Emerg Infect Dis· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus inactivation during the freeze-drying processes as used for the manufacture of plasma-derived medicinal products.
Ulrike Unger, Gerhard Poelsler, Jens Modrof, Thomas R Kreil

Transfusion· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.
Andreas Berting, Jens Modrof, Ulrike Unger, Matthias Gessner, Andreas Klotz

Transfusion· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.
Jens Modrof, Andreas Berting, Björn Tille, Andreas Klotz, Christina Forstner

Transfusion· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
West Nile virus neutralization by US plasma-derived immunoglobulin products.
Christina B Planitzer, Jens Modrof, Thomas R Kreil

J Infect Dis· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies.
Jens Modrof, Kostas Lymperopoulos, Polly Roy

J Virol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide.
Bettina Hartlieb, Jens Modrof, Elke Mühlberger, Hans-Dieter Klenk, Stephan Becker

J Biol Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ebola virus transcription activator VP30 is a zinc-binding protein.
Jens Modrof, Stephan Becker, Elke Mühlberger

J Virol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation of VP30 impairs ebola virus transcription.
Jens Modrof, Elke Mühlberger, Hans-Dieter Klenk, Stephan Becker

J Biol Chem· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.
Michael Weik, Jens Modrof, Hans-Dieter Klenk, Stephan Becker, Elke Mühlberger

J Virol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis